文献速递肺结节与肺癌

外周T1肺肿瘤或需扩大有创纵隔分期

Evidence for Expanding Invasive Mediastinal Staging for Peripheral T1 Lung Tumors.
PubMed 文献 · Chest · 2020-06-26

肿瘤大小及位置与淋巴结转移率无显著关联,提示小外周肺癌患者可能受益于有创纵隔分期。

要点

  • T1肺癌淋巴结转移率较高,研究中达20.8%。
  • 肿瘤直径与淋巴结转移风险无显著关联。
  • 肿瘤位置(距隆突距离或坐标)与淋巴结转移无显著关联。

核心结论

  • T1肺癌中N2转移率较高,且肿瘤直径或位置与淋巴结转移无显著关系,提示小外周肺癌患者可能受益于有创纵隔分期。

研究设计与样本

  • 通过CT数据转换确定癌症位置及X、Y、Z坐标和距主隆突距离,构建多变量逻辑回归模型评估淋巴结转移预测因素。

主要发现

  • 基于肿瘤大小的淋巴结转移率无差异(OR,1.03;P = .248)。
  • 基于距隆突距离(OR,0.99;P = .156)或肿瘤坐标(X: P = .180;Y: P = .311;Z: P = .292)的淋巴结转移率无统计学差异。
  • 调整年龄、性别、组织学和吸烟史后,风险幅度无变化,显著性检验未改变。

临床怎么用

  • 对于小外周T1肺癌患者,应考虑进行有创纵隔分期以评估N2转移风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Guidelines recommend invasive mediastinal staging for patients with non-small cell lung cancer and a "central" tumor. However, there is no consensus definition for central location. As such, the decision to perform invasive staging largely remains on an empirical foundation. RESEARCH QUESTION: Should patients with peripheral T1 lung tumors undergo invasive mediastinal staging? STUDY DESIGN AND METHODS: All participants with a screen-detected cancer with a solid component between 8 and 30 mm were identified from the National Lung Screening Trial. After translation of CT data, cancer location was identified and the X, Y, Z coordinates were determined as well as distance from the main carina. A multivariable logistic regression model was constructed to evaluate for predictors associated with lymph node metastasis. RESULTS: Three hundred thirty-two participants were identified, of which 69 had lymph node involvement (20.8%). Of those with lymph node metastasis, 39.1% were N2. There was no difference in rate of lymph node metastasis based on tumor size (OR, 1.03; P = .248). There was also no statistical difference in rate of lymph node metastasis based on location, either by distance from the carina (OR, 0.99; P = .156) or tumor coordinates (X: P = .180; Y: P = .311; Z: P = .292). When adjusted for age, sex, histology, and smoking history, there was no change in the magnitude of the risk, and tests of significance were not altered. INTERPRETATION: Our data indicate a high rate of N2 metastasis among T1 tumors and no significant relationship between tumor diameter or location. This suggests that patients with small, peripheral lung cancers may benefit from invasive mediastinal staging.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. DuComb EA, Tonelli BA, Tuo Y, et al. Evidence for Expanding Invasive Mediastinal Staging for Peripheral T1 Lung Tumors. Chest. 2020. PMID: 32599066. doi:10.1016/j.chest.2020.05.607

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。